Literature DB >> 21199453

Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.

Jin-Hyun Woo1, Sungeun Kim, Seong J Choi, Young H Lee, Jong D Ji, Gwan G Song.   

Abstract

Sclerotic lesions of the right iliac bone were discovered incidentally in a 52-year-old Korean woman. In this case, imaging of the right iliac bone showed intense osteoblastic activity on the bone scan and very mild F-18-fluoro-2-deoxyglucose (FDG) uptake on positron emission tomography (PET). Since Paget's disease is rare in Koreans, we aimed to rule out other bone diseases such as osteoblastic metastasis or osteomyelitis. These results allowed us to exclude chronic osteomyelitis or malignancy and clarify the diagnosis of Paget's disease of the iliac bone. This case illustrates how F-18 FDG PET/CT can be a useful tool in the differential diagnosis of various bone diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21199453     DOI: 10.1111/j.1756-185X.2010.01538.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

Review 1.  Imaging of Paget's disease of bone.

Authors:  Naomi Winn; Radhesh Lalam; Victor Cassar-Pullicino
Journal:  Wien Med Wochenschr       Date:  2016-10-19

2.  Paget's sarcoma of the patella.

Authors:  Salman Ansari; Fiona Bonar; Paul Stalley; Wendy Brown
Journal:  Skeletal Radiol       Date:  2015-04-12       Impact factor: 2.199

3.  Imaging features of Paget's disease on 11C choline PET/CT.

Authors:  Cameron E Leitch; Ajit H Goenka; Benjamin M Howe; Stephen M Broski
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

4.  Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study.

Authors:  Stefan T G Bruijnen; Mignon A C van der Weijden; Joannes P Klein; Otto S Hoekstra; Ronald Boellaard; J Christiaan van Denderen; Ben A C Dijkmans; Alexandre E Voskuyl; Irene E van der Horst-Bruinsma; Conny J van der Laken
Journal:  Arthritis Res Ther       Date:  2012-04-02       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.